1-2 of 2
Chandra P Belani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Combined Safety and Tolerability Profile of Vorinostat-Based Therapy for Solid or Hematologic Malignancies.

David Siegel, Pamela N Munster, Eric Rubin, Marian Iwamoto, Simon van Belle, Mohamad Hussein, MD, Chandra P Belani, Francisco Robert, Evanthia Galanis, James Hardwick, Syed Rizvi
Journal: Blood
Blood (2009) 114 (22): 1710.
https://doi.org/10.1182/blood.V114.22.1710.1710
Published: 2009
Journal Articles

Combination of Proteasome Inhibitor PS 341 (Velcade®) with Histone Acetylase Inhibitor (HDAC) PXD 101 Shows Superior Anti-Myeloma Activity and Inhibits Osteoclastogenesis.

Suzanne Lentzsch, MD, PhD, Gulsum Anderson, PhD, Cuiling Li, PhD, Chandra P. Belani, MD, Markus Y. Mapara, MD, PhD, David Roodman, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2488.
https://doi.org/10.1182/blood.V106.11.2488.2488
Published: 2005